Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease.

Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group.

Mayo Clin Proc. 2019 Oct;94(10):2054-2071. doi: 10.1016/j.mayocp.2019.02.023. Epub 2019 Aug 28. Review.

PMID:
31472931
2.

Management of Multiple Sclerosis Symptoms and Comorbidities.

Tobin WO.

Continuum (Minneap Minn). 2019 Jun;25(3):753-772. doi: 10.1212/CON.0000000000000732.

PMID:
31162315
3.

Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up.

Petzold A, Woodhall M, Khaleeli Z, Tobin WO, Pittock SJ, Weinshenker BG, Vincent A, Waters P, Plant GT.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1021-1026. doi: 10.1136/jnnp-2019-320493. Epub 2019 May 22.

PMID:
31118222
4.

Extracranial and Intracranial Vasculopathy With "Moyamoya Phenomenon" in Association With Alagille Syndrome.

Delaney S, O'Connor G, Reardon W, Murphy SJX, Tierney S, Ryan BM, Delaney H, Doherty CP, Guiney M, Brennan P, Tobin WO, McCabe DJH.

Front Neurol. 2019 Jan 29;9:1194. doi: 10.3389/fneur.2018.01194. eCollection 2018.

5.

Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms.

Goyal G, Lau D, Nagle AM, Vassallo R, Rech KL, Ryu JH, Davidge-Pitts CJ, Tobin WO, Koster MJ, Bennani NN, Shah MV, Liu MC, Go RS; Mayo Clinic Histiocytosis Working Group.

Blood. 2019 Apr 4;133(14):1607-1610. doi: 10.1182/blood-2018-12-893917. Epub 2019 Jan 29. No abstract available.

PMID:
30696619
6.

Image-based multi-scale mechanical analysis of strain amplification in neurons embedded in collagen gel.

Chan VWL, Tobin WR, Zhang S, Winkelstein BA, Barocas VH, Shephard MS, Picu CR.

Comput Methods Biomech Biomed Engin. 2019 Feb;22(2):113-129. doi: 10.1080/10255842.2018.1538414. Epub 2018 Nov 17.

PMID:
30450957
7.

Growing the phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) in children.

Tobin WO.

Dev Med Child Neurol. 2019 Apr;61(4):391-392. doi: 10.1111/dmcn.14043. Epub 2018 Sep 23. No abstract available.

PMID:
30246371
8.

Population-based study of "no evident disease activity" in MS.

Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 16;5(6):e495. doi: 10.1212/NXI.0000000000000495. eCollection 2018 Nov.

9.

Reply: Two cases of CLIPPERS with increased number of perivascular CD20-positive B lymphocytes.

Tobin WO, Guo Y, Keegan BM.

Brain. 2018 Oct 1;141(10):e76. doi: 10.1093/brain/awy236. No abstract available.

PMID:
30203037
10.

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.

Am J Ophthalmol. 2018 Nov;195:8-15. doi: 10.1016/j.ajo.2018.07.020. Epub 2018 Jul 26.

11.

Reply to: "Crowell et al. Idiopathic Central Nervous System Inflammatory Disease in the Setting of HLA-B27 Uveitis".

Tobin WO, Keegan BM.

Ocul Immunol Inflamm. 2019;27(6):918-919. doi: 10.1080/09273948.2018.1484497. Epub 2018 Jun 29. No abstract available.

PMID:
29958047
12.

Teaching NeuroImages: Optic nerve sheath meningioma presenting as gaze-evoked amaurosis.

Johnson SAA, Chen JJ, Tobin WO.

Neurology. 2018 Jun 5;90(23):e2095-e2096. doi: 10.1212/WNL.0000000000005642. No abstract available.

PMID:
29866943
13.

Focusing on the Big Picture: Induced Focal Seizures Propagate Along Synaptic Pathways.

Tobin WF, Weston MC.

Epilepsy Curr. 2018 Jan-Feb;18(1):47-48. doi: 10.5698/1535-7597.18.1.47. No abstract available.

14.

Neuromyelitis Optica and Herpes Simplex Virus 2: A Viral Trigger for Aquaporin-4 Autoimmunity?

Marin Collazo IV, Howe CL, Lucchinetti CF, Tobin WO.

Neurologist. 2018 May;23(3):92-93. doi: 10.1097/NRL.0000000000000172.

PMID:
29722742
15.

Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.

Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ.

Ophthalmology. 2018 Oct;125(10):1628-1637. doi: 10.1016/j.ophtha.2018.03.041. Epub 2018 Apr 30.

PMID:
29716788
16.

Clinical Reasoning: A 30-year-old man with headache and sleep disturbance.

English SW, Keegan BM, Flanagan EP, Tobin WO, Zalewski NL.

Neurology. 2018 Apr 24;90(17):e1535-e1540. doi: 10.1212/WNL.0000000000005356. No abstract available.

PMID:
29686126
17.

Neuroradiologic manifestations of Erdheim-Chester disease.

Parks NE, Goyal G, Go RS, Mandrekar J, Tobin WO.

Neurol Clin Pract. 2018 Feb;8(1):15-20. doi: 10.1212/CPJ.0000000000000422.

18.

Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.

Chen JJ, Tobin WO, Majed M, Jitprapaikulsan J, Fryer JP, Leavitt JA, Flanagan EP, McKeon A, Pittock SJ.

JAMA Ophthalmol. 2018 Apr 1;136(4):419-422. doi: 10.1001/jamaophthalmol.2017.6757.

19.

Facial Myokymia and Hemifacial Spasm in Multiple Sclerosis: A Descriptive Study on Clinical Features and Treatment Outcomes.

Marin Collazo IV, Tobin WO.

Neurologist. 2018 Jan;23(1):1-6. doi: 10.1097/NRL.0000000000000163.

PMID:
29266036
20.

Reply: A case of CLIPPERS challenging the new diagnostic criteria.

Tobin WO, Guo Y, Krecke KN, Keegan BM.

Brain. 2018 Feb 1;141(2):e13. doi: 10.1093/brain/awx336. No abstract available.

PMID:
29244097
21.

Reply: CLIPPERS, a possible symptomatic lymphohistiocytic immune reaction.

Tobin WO, Guo Y, Keegan BM.

Brain. 2018 Jan 1;141(1):e6. doi: 10.1093/brain/awx299. No abstract available.

PMID:
29161360
22.

Efficacy of biological agents in the treatment of Erdheim-Chester disease.

Goyal G, Shah MV, Call TG, Litzow MR, Wolanskyj-Spinner AP, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Hook CC, Hogan WJ, Go RS.

Br J Haematol. 2018 Nov;183(3):520-524. doi: 10.1111/bjh.14997. Epub 2017 Oct 30. No abstract available.

PMID:
29082516
23.

Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, Mandrekar J, Dubey D, Debruyne J, Keegan BM.

Brain. 2017 Sep 1;140(9):2415-2425. doi: 10.1093/brain/awx200.

PMID:
29050399
24.

CLIPPERS.

Zalewski NL, Tobin WO.

Curr Neurol Neurosci Rep. 2017 Sep;17(9):65. doi: 10.1007/s11910-017-0773-7. Review.

PMID:
28726127
25.

Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - NO.

Tobin WO, Weinshenker BG.

Mult Scler. 2017 Aug;23(9):1190-1192. doi: 10.1177/1352458517702556. Epub 2017 Jul 4. No abstract available.

PMID:
28673112
26.

Autoimmune Neurology of the Central Nervous System.

Tobin WO, Pittock SJ.

Continuum (Minneap Minn). 2017 Jun;23(3, Neurology of Systemic Disease):627-653. doi: 10.1212/CON.0000000000000487. Review.

PMID:
28570322
27.

Wiring variations that enable and constrain neural computation in a sensory microcircuit.

Tobin WF, Wilson RI, Lee WA.

Elife. 2017 May 22;6. pii: e24838. doi: 10.7554/eLife.24838.

28.

Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.

Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Egan B, Feeley TM, Coughlan T, Collins DR, O'Neill D, Murphy S, Lim SJ, Murphy RP, McCabe D.

J Neurol Sci. 2017 Apr 15;375:404-410. doi: 10.1016/j.jns.2017.02.045. Epub 2017 Feb 24.

PMID:
28320178
29.

Clinical-radiological-pathological spectrum of central nervous system-idiopathic inflammatory demyelinating disease in the elderly.

Tobin WO, Costanzi C, Guo Y, Parisi JE, Weigand SD, Lucchinetti CF.

Mult Scler. 2017 Aug;23(9):1204-1213. doi: 10.1177/1352458516675748. Epub 2016 Oct 19.

30.

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG.

Neurology. 2016 Sep 27;87(13):1393-9. doi: 10.1212/WNL.0000000000003152. Epub 2016 Aug 31.

31.

A randomized, crossover pharmacodynamic study of immediate-release omeprazole/sodium bicarbonate and delayed-release lansoprazole in healthy adult volunteers.

Pratha VS, McGraw T, Tobin W.

Pharmacol Res Perspect. 2016 May 19;4(3):e00238. doi: 10.1002/prp2.238. eCollection 2016 Jun.

32.

Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló's concentric sclerosis.

Hardy TA, Tobin WO, Lucchinetti CF.

Mult Scler. 2016 Jul;22(8):986-92. doi: 10.1177/1352458516641776. Epub 2016 Apr 1. Review.

PMID:
27037180
33.

Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings.

Tobin WO, Popescu BF, Lowe V, Pirko I, Parisi JE, Kantarci K, Fields JA, Bruns MB, Boeve BF, Lucchinetti CF.

Mult Scler. 2016 Apr;22(5):698-704. doi: 10.1177/1352458515604382. Epub 2015 Oct 7.

34.

Stopping immunomodulatory medications in MS: Frequency, reasons and consequences.

Tobin WO, Weinshenker BG.

Mult Scler Relat Disord. 2015 Sep;4(5):437-443. doi: 10.1016/j.msard.2015.07.004. Epub 2015 Jul 8. Review. Erratum in: Mult Scler Relat Disord. 2016 Jan;5():105.

PMID:
26346792
35.

Diagnostic Yield and Safety of Cerebellar and Brainstem Parenchymal Biopsy.

Tobin WO, Meyer FB, Keegan BM.

World Neurosurg. 2015 Dec;84(6):1973-6. doi: 10.1016/j.wneu.2015.08.062. Epub 2015 Sep 2.

PMID:
26342777
36.

Teaching NeuroImages: Primary Sjögren syndrome presenting as isolated lesion of medulla oblongata.

Tobin WO, Pittock SJ, Weinshenker BG.

Neurology. 2015 Jul 14;85(2):204-5. doi: 10.1212/01.wnl.0000469900.24335.36. No abstract available.

PMID:
26170403
37.

Rituximab Therapy in Neuromyelitis Optica: Moving Toward a Personalized Medicine Approach.

Tobin WO, Pittock SJ.

JAMA Neurol. 2015 Sep;72(9):974-7. doi: 10.1001/jamaneurol.2015.1421. No abstract available.

PMID:
26168370
38.

Cervical artery dissection in young adults in the stroke in young Fabry patients (sifap1) study.

von Sarnowski B, Schminke U, Grittner U, Fazekas F, Tanislav C, Kaps M, Tatlisumak T, Putaala J, Haeusler KG, Borges do Amaral E Silva AD, Kinsella JA, McCabe DJ, Tobin WO, Huber R, Willeit J, Furtner M, Bodechtel U, Rolfs A, Kessler C, Hennerici MG.

Cerebrovasc Dis. 2015;39(2):110-21. doi: 10.1159/000371338. Epub 2015 Jan 23.

PMID:
25634656
39.

NMDA receptor encephalitis causing reversible caudate changes on MRI and PET imaging.

Tobin WO, Strand EA, Clark HM, Lowe VJ, Robertson CE, Pittock SJ.

Neurol Clin Pract. 2014 Dec;4(6):470-473. No abstract available.

40.

DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.

Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A.

Neurology. 2014 Nov 11;83(20):1797-803. doi: 10.1212/WNL.0000000000000991. Epub 2014 Oct 15.

41.

Increased thrombin generation potential in symptomatic versus asymptomatic moderate or severe carotid stenosis and relationship with cerebral microemboli.

Kinsella JA, Tobin WO, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Feeley TM, Egan B, O'Neill D, Collins DR, Coughlan T, Harbison JA, Doherty CP, Madhavan P, Moore DJ, O'Neill SM, Colgan MP, Saqqur M, Murphy RP, Moran N, Hamilton G, McCabe DJ.

J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):460-7. doi: 10.1136/jnnp-2013-307556. Epub 2014 Jul 17.

PMID:
25033981
42.

Longitudinally extensive transverse myelitis.

Tobin WO, Weinshenker BG, Lucchinetti CF.

Curr Opin Neurol. 2014 Jun;27(3):279-89. doi: 10.1097/WCO.0000000000000093. Review.

PMID:
24792338
43.

Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.

Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Coughlan T, Collins DR, O'Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ.

J Neurol. 2014 Jul;261(7):1405-12. doi: 10.1007/s00415-014-7362-3. Epub 2014 Apr 30.

PMID:
24781842
44.

Increased endothelial activation in recently symptomatic versus asymptomatic carotid artery stenosis and in cerebral microembolic-signal-negative patient subgroups.

Kinsella JA, Tobin WO, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Feeley TM, Egan B, O'Neill D, Collins RD, Coughlan T, Harbison JA, Doherty CP, Madhavan P, Moore DJ, O'Neill SM, Colgan MP, Saqqur M, Murphy RP, Moran N, Hamilton G, McCabe DJ.

Eur J Neurol. 2014 Jul;21(7):969-e55. doi: 10.1111/ene.12403. Epub 2014 Apr 9.

PMID:
24712648
45.

Sexual dimorphism in clinical neurology--predictors of successful lumbar puncture in an "expanding" population.

Power SP, Costello DJ, Tobin WO.

Obesity (Silver Spring). 2014 Jul;22(7):1747-9. doi: 10.1002/oby.20745. Epub 2014 Apr 4.

46.

Frequent inaccuracies in ABCD2 scoring in non-stroke specialists' referrals to a daily Rapid Access Stroke Prevention service.

Bradley D, Cronin S, Kinsella JA, Tobin WO, Mahon C, O'Brien M, Lonergan R, Cooney MT, Kennelly S, Collins DR, O'Neill D, Coughlan T, Smyth S, McCabe DJ.

J Neurol Sci. 2013 Sep 15;332(1-2):30-4. doi: 10.1016/j.jns.2013.05.030. Epub 2013 Jul 17.

PMID:
23871489
47.

Increased platelet activation in early symptomatic vs. asymptomatic carotid stenosis and relationship with microembolic status: results from the Platelets and Carotid Stenosis Study.

Kinsella JA, Tobin WO, Tierney S, Feeley TM, Egan B, Collins DR, Coughlan T, O'Neill D, Harbison J, Madhavan P, Moore DJ, O'Neill SM, Colgan MP, Doherty CP, Murphy RP, Saqqur M, Moran N, Hamilton G, McCabe DJ.

J Thromb Haemost. 2013 Jul;11(7):1407-16. doi: 10.1111/jth.12277.

48.

Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patients.

von Sarnowski B, Schminke U, Tatlisumak T, Putaala J, Grittner U, Kaps M, Tobin WO, Kinsella JA, McCabe DJ, Hennerici MG, Fazekas F, Norrving B, Kessler C, Rolfs A; sifap1 investigators.

Neurology. 2013 Apr 2;80(14):1287-94. doi: 10.1212/WNL.0b013e31828ab2ed. Epub 2013 Mar 6.

PMID:
23468548
49.

Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.

Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RA, Collins DR, Coughlan T, O'Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ.

J Neurol. 2013 Feb;260(2):590-6. doi: 10.1007/s00415-012-6684-2. Epub 2012 Oct 14.

PMID:
23064666
50.

Platelet activation, function, and reactivity in atherosclerotic carotid artery stenosis: a systematic review of the literature.

Kinsella JA, Tobin WO, Hamilton G, McCabe DJ.

Int J Stroke. 2013 Aug;8(6):451-64. doi: 10.1111/j.1747-4949.2012.00866.x. Epub 2012 Sep 27. Review.

PMID:
23013536

Supplemental Content

Support Center